Natalie Pankova, PhD

Global Leader in Healthcare Technology & Innovation | Venture Capital Pre-Seed Investor, Board Member & Advisor

United Kingdom

About

Investment, Venture Building and Operational Leadership on a Global Scale, in Health & Biotechnology, Diagnostics & Therapeutics Development, Personalized and Precision Medicine, Machine Learning & Artificial Intelligence, Decentralized Computing, Deeptech Highly specialized in ophthalmology with a focus on retinal degeneration. Also exploring indications in Women's Health, Inflammatory and Cardiometabolic Disease.

Experience

  • Zinc (3 yrs 7 mos)
    • Partner, Health & Life Sciences
      Mar 2025 - Present · 1 yr 4 mos

    • MD, Deeptech & Health
      Dec 2022 - Mar 2025 · 2 yrs 4 mos

  • Novai (5 yrs 7 mos)
    • Board Member
      Dec 2020 - Present · 5 yrs 7 mos

    • Consulting COO & Technology Lead
      Feb 2022 - Jan 2023 · 1 yr

  • Guest Lecturer at UCL Global Business School for Health
    Sep 2022 - Present · 3 yrs 10 mos

    Leadership in AI for Healthcare, Research for Management

  • Director, Board Member, Advisor & Consultant at Digital Health | Precision Medicine | Ophthalmology | AI & Blockchain | Healthcare Investment
    Nov 2017 - Present · 8 yrs 8 mos

    - Fractional COO/CSO, advising, mentoring and coaching early stage startups and SMEs, specializing in digital health, biotech, precision medicine and deep tech space - Coaching and supporting across growth and innovation strategy, scaling teams and business lines, employing technologies such as AI and blockchain, product and business model development, raising financing and company operations including implementation and use of disciplined agile methodologies - including through the EIC Accelerator and Horizon Europe programs - Serving on boards of multiple innovative companies and organisations overseeing corporate governance and business strategic direction.

  • Cube Labs (4 yrs 4 mos)
    • Operations Advisor
      Feb 2023 - Present · 3 yrs 5 mos

    • Chief Operating Officer (Consulting)
      Mar 2022 - Mar 2023 · 1 yr 1 mo

      European Venture Builder at the intersection of life science and advanced technologies